Table of Contents
Cover
Title Page
Copyright
Dedication
Foreword
List of Contributors
Preface
About the Companion Website
Part 1: Introduction
Chapter 1: History of cardiac pacing and defibrillation in the young
Leads
Pacing modes
Non-invasive programmability
Multiprogrammability
Miniaturization
Pacemaker codes
Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices
North American Society of Pacing and Electropysiology (NASPE)
The implantable cardioverter defibrillator (ICD)
Summary
References
Chapter 2: Clinically relevant basics of pacing and defibrillation
Basic concepts in cardiac pacing
Engineering aspects of transvenous pacemaker leads and generators
ICD therapies
Cardioversion
Defibrillation
ICD monitoring, algorithms, and alerts
Remote monitoring
References
Part 2: Clinical Concepts
Chapter 3: Indications for permanent pacing, device, and lead selection
Introduction
Section 1: indications for permanent pacemaker implantation
Section 2: lead selection
Section 3: device selection
Conclusions
References
Chapter 4: Indications for implantable cardioverter defibrillator therapy, device, and lead selection
Introduction
ICD indications in patients with congenital heart disease (CHD)
ICD indications in hypertrophic cardiomyopathy (HCM)
ICD indications in patients with long QT syndrome (LQTS)
ICD implantation in catecholaminergic polymorphic ventricular tachycardia (CPVT)
ICD implantation in Brugada syndrome (BrS)
ICD indications in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)
ICD code
ICD generator selection
V sensing and refractory (unique to devices)
Subcutaneous ICD
Conclusions
References
Chapter 5: Hemodynamics of pacing and cardiac resynchronization therapy (CRT) for the failing left and right ventricle
Physiology of electrical and mechanical activation
Abnormal activation sequence during bundle branch block
Site specific hemodynamics of pacing
Strategies to restore ventricular synchrony in adult heart failure
Strategies to restore synchrony in pediatric and congenital heart disease
Conclusions
References
Chapter 6: Sensor driven pacing: Ideal characteristics in pediatrics
Introduction
Basic physiology of exercise
Characteristics of an ideal rate-adaptive pacing system
Sensors
Conclusion
References
Chapter 7: Implantable cardioverter-defibrillator testing in pediatric and congenital heart disease
Fibrillation and defibrillation
Defibrillation threshold testing and lowest energy tested
Common methods of determining DFT in pediatrics and CHD in the current era
Upper limit of vulnerability
Equipment and personnel readiness for defibrillation testing at implant
Factors that affect DFTs
Approach to the patient with high DFTs
Retesting of the DFT in pediatric and congenital heart disease
Follow-up DFTs in non-transvenous ICD configurations
Conclusions
References
Part 3: Implantation Techniques
Chapter 8: Permanent transvenous pacemaker, CRT, and ICD implantation in the structurally normal heart
Introduction
Procedural requirements and patient selection
Transvenous access and site selection
Lead placement in the structurally normal heart
Device location and pocket creation
Approach to the generator change
Conclusion
References
Chapter 9: Permanent pacemaker, CRT, and ICD implantation in congenital heart disease
Indications for pacemaker placement in patients with congenital heart disease
Recommendations for pacemaker placement in pediatric and CHD
Recommendations for implantable cardioverter defibrillator placement in patients with CHD
Implanting the device
Unique scenarios for pacemaker or ICD implantation in patients with congenital heart disease
Resynchronization therapy
Assessment of dyssynchrony in congenital heart disease
Implantation of a CRT device
References
Chapter 10: Permanent epicardial pacing: When, how, and why?
Introduction
Patient size
Patient anatomy and physiology
Lead placement and cardiomyopathy
Lead longevity and implantation
Epicardial pacing in specific patient substrates
Types of epicardial pacing leads and implantation approaches
Complications after epicardial pacemaker implantation
Conclusion
References
Chapter 11: Managing device related complications and lead extraction
Introduction
Implant-related complications
Transvenous leads
Arrhythmias during implantation
Lead perforation
The pulse generator pocket
Venous thrombosis
Lead extraction
Summary
References
Chapter 12: Temporary pacing in children
Introduction
Approaches to temporary pacing
Conclusion
References
Part 4: Device Programming and Follow-Up
Chapter 13: Pacemaker and ICD programming in congenital heart disease
Pacemaker programming
ICD programming
References
Chapter 14: Pacemaker troubleshooting and follow-up
Pacemaker programming for unique conditions
Sensing issues
Maladaptive pacemaker function in the young patient or patient with repaired congenital heart disease
Loss of capture issues
Upper rate behaviors
Automatic mode switch algorithms
Pacemaker mediated tachycardia
Pacemaker crosstalk
Noise reversion
Pacemakers and MRI
Follow-up
References
Chapter 15: ICD troubleshooting and follow-up
Introduction
ICD therapy
Nonphysiologic oversensing
Failure to deliver therapy
Unsuccessful therapy
Small caliber ICD lead failures
ICD generator failures
Conclusion
References
Chapter 16: CRT device programming and optimization
Introduction
Programming the device
Monitoring CRT response
CRT optimization
Optimization in pediatrics and congenital heart disease
Conclusion
References
Chapter 17: Implantable syncope and arrhythmia monitors, and automated external defibrillators
Introduction
Implantable loop recorders
Conclusion
References
Chapter 18: Electromagnetic interference and implantable devices
Background
When to suspect electromagnetic interference
Sources of electromagnetic interference
Cardiovascular implanted electronic devices and magnetic resonance imaging
References
Chapter 19: Quality of life, sports, and implantable devices in the young
Introduction
Description of the topic
Quality of Life
Sports participation
References
Chapter 20: Device innovations and the future of device therapy for arrhythmia and heart failure management
Introduction and the legacy of cardiac rhythm management devices
Toward a better energy source
Preserving vascular access in our young patients
Leads and conductors
Out-patient monitoring
Cardiac rhythm management devices in low and middle income countries
References
Glossary
Index
End User License Agreement
Pages
ix
xi
xii
xiii
xv
xvi
xvii
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
325
326
327
328
329
330
331
Guide
cover
Table of Contents
Preface
Begin Reading